Resonant frequency therapy
Resonant frequency therapy (RFT) is an electromagnetic energy treatment used to address various conditions and illnesses. Based on the theory that all living organisms emit electromagnetic frequencies, targeting cancer cell specific frequencies through RFT allows targeted destruction while sparing healthy tissue. RFT may also stimulate natural healing mechanisms within the body without negatively impacting them.
Resonance frequencies are electromagnetic energies that resonate with certain molecules in living tissue and can be generated using electromagnetic radiation-generating devices like radio or light. Studies have revealed that using resonance frequencies to treat various conditions, including arthritis, tinnitus, high blood pressure headaches and shingles has been found beneficial; possibly as the interaction of resonance frequencies with specific molecular structures (ions or enzymes).
Resonant frequencies associated with DNA and RNA occur naturally within the electromagnetic spectrum, predominantly within the infrared region. Current frequency-emitting devices tend to only produce frequencies in narrow wavelength ranges; using methods provided here, therapeutic or beneficial resonant frequencies can be determined for genomic materials situated among media of differing refractivities.
At present, the therapeutic resonant frequency for human tyrosine kinase messenger RNA is 3151 bases long; this corresponds to an infrared region frequency. A device capable of producing frequencies in this region, such as electronic scanning devices can then be programmed accordingly.
Microcurrent therapy
Resonant frequency therapy (RFT) is a noninvasive therapy that leverages the body’s own natural healing processes to promote harmony within all aspects of wellbeing, from physical to mental and emotional. RFT helps alleviate pain, improve sleep quality and cognitive performance as well as decrease stress while supporting immune systems for overall wellness and vitality.
This treatment works on the principle that all living organisms, including cancer cells, emit electromagnetic frequencies. If we can identify which frequencies cancer cells emit specifically then using magnetic fields with matching frequencies could potentially destroy them; however, no conclusive scientific evidence exists yet proving its efficacy.
To efficiently identify therapeutic resonance frequencies for genomic material within in-vivo tissues, divide the resonant frequency of the genome by its refractive index value; this allows a frequency in the audio range to be quickly and accurately determined. For example, Borrelia burgdorferi genome’s resonant frequency is 3.41515016Hz which when divided by in-vivo tissues’ refractive index gives us audio range frequency that can then be multiplied by positive integers to obtain harmonic frequencies, and subharmonic frequencies which allow targeted genomic material’s influence to influence targets within tissues quickly and accurately.
Methods of identifying therapeutic resonant frequencies have the potential to enhance medical device effectiveness for treating specific diseases. For instance, laboratory research has demonstrated that exposing Escherichia coli bacteria to gene-related resonant frequencies reduces their colony count due to binding with DNA structures that alter structural and functional characteristics of bacteria colonies in culture.
